Top1000 Scholar

Scholarly Index

Hatem A. Abdel‐Aziz

National Research Centre; 7,673 total citations; 308 total publications; best world rank #27

National Research Centre

7,673Total citations
308Total publications
55H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Chemistry2021-2025616EG 796.26
Organic ChemistryLifetime780EG 198.36
Medicinal and Pharmaceutical ChemistryLifetime63EG 196.75
Organic Chemistry2021-2025308EG 693.69
Clinical Pharmacology2021-2025298EG 287.92
Medicinal and Pharmaceutical Chemistry2021-202527EG 487.22
Heterocyclic Compound Synthesis and BioactivityLifetime75EG 299.14
Synthesis and Characterization of Heterocyclic CompoundsLifetime74EG 299.00
Synthesis and Biological EvaluationLifetime173EG 198.61
Synthesis of heterocyclic compoundsLifetime122EG 497.83
Quinazolinone synthesis and applicationsLifetime114EG 596.88
Synthesis and Reactions of Organic CompoundsLifetime371EG 597.19
Cancer therapeutics and mechanismsLifetime700EG 296.62
Synthesis of Organic CompoundsLifetime447EG 595.25
Bioactive Compounds and Antitumor AgentsLifetime507EG 495.11
Phenothiazines and Benzothiazines Synthesis and ActivitiesLifetime822EG 1991.59
Cancer Mechanisms and TherapyLifetime989EG 691.64
Enzyme function and inhibitionLifetime492EG 392.48
Synthesis and Reactivity of HeterocyclesLifetime673EG 2191.08
Heterocyclic Compound Synthesis and Bioactivity2021-2025162EG 3297.29
Cancer Mechanisms and Therapy2021-202577EG 594.23
Cancer therapeutics and mechanisms2021-2025169EG 2690.35
Inflammatory mediators and NSAID effects2021-2025107EG 687.97
Enzyme function and inhibition2021-202549EG 491.13
Synthesis and Characterization of Heterocyclic Compounds2021-2025276EG 5089.80
Cholinesterase and Neurodegenerative Diseases2021-2025295EG 685.92
Cancer-related Molecular Pathways2021-2025502EG 580.87
Quinazolinone synthesis and applications2021-2025209EG 5279.76
Chemical Reactions and Mechanisms2021-202562EG 277.54
Synthesis and Catalytic Reactions2021-2025966EG 772.83
Bioactive Compounds and Antitumor Agents2021-2025810EG 7561.29